>> Главная

The Documentation About "Codex Alimentarius"

Suppression of Use of Vitamins Against Common Disorders
-- Cancer

In the industrialized world, cancer is the second-leading cause of death. The pharmaceutical industry's market for cancer drugs is one of the most lucrative and inhumane aspects of the "business with disease."


The second largest market for pharmaceuticals is the treatment
of cancer with chemotherapeutics and other useless pharmaceuticals.

Particularly deplorable is chemotherapy. The drugs kill both cancer cells and healthy cells, bringing the patient to the edge of death. The procedures produce crippling and life-threatening side effects that demand further drugs. Therefore chemotherapy necessitates a whole series of subsequent treatments (creating markets for ancillary sales). Cancer chemotherapy with cytotoxic chemicals is aberrant medicine for the following reasons:

There is no evidence to date that the therapy prolongs life. Physicians rarely prescribe chemotherapy for themselves. The only sure thing is that the cancer market is the second-largest market for pharmaceuticals, after the market for cardiovascular disease, with billions of dollars in sales.

Cellular medicine offers the only rational and plausible prevention and treatment of cancer. Vitamin C and other antioxidants protect cells from carcinogenesis. The amino acid lysine protects the surrounding connective tissue, thereby providing resistance to the propagation and metastasis of cancer.

If the Codex conspiracy succeeds, millions more will die unnecessarily from cancer.

Sitemap

   

Type a keyword and click on the 'Go' button to begin full-text search throughout the site.

 Printer-friendly page

Send page to a friend Send page to a friend

Bookmark this page Bookmark this page

>> Natural Health Care

>> Studies Worldwide

>> "Business With Disease"

>> International Campaign

>> Open Letter Campaign

>> Take Action

>> Features

 © 2008 Dr. Rath Health Foundation Send page to a friend contact Printer-friendly page Help Previous document Top of the page Function not available in this page Back to Homepage